Digoxin is a cardiac glycoside that inhibits sodium-potassium ATPase. The resulting changes in ion handling influence cardiac contraction and conduction. Blood concentration, tissue exposure and clinical response are related measurements with different time courses.[ref]
Articles by others on the same topic
There are currently no matching articles.